Seroprevalence of Anti-SARS-CoV-2 IgG Antibodies among HIV Infected Individuals Attending ART Centre at Pune: A Cross-Sectional Study.
J Int Assoc Provid AIDS Care
; 21: 23259582221077943, 2022.
Article
in English
| MEDLINE | ID: covidwho-1673885
ABSTRACT
Background:
We aimed to determine the anti-SARS-CoV-2 IgG antibodies among people living with HIV (PLHIV) in Pune, India.Methods:
This cross-sectional study was conducted between March 2021 and June 2021. Demographic and clinical information related to coronavirus disease 2019 (COVID-19) were recorded on structured questionnaires. Blood samples were collected and tested for anti-SARS-CoV-2 IgG antibodies using commercial ELISA.Results:
Of the 405 HIV infected individuals enrolled in the study, 223(55.1%) were females. Mean age and CD4 count of participants were 42 years (SD 10) and 626 cells/mm3 (SD 284) respectively. A total of 382 (95%) PLHIV were virologically suppressed. The seropositivity against SARS-CoV-2 was found in 221 PLHIV (54.6%, 95% CI 49.7-59.4). No significant association was found between demographic or clinical factors and seropositivity.Conclusion:
A high prevalence of anti-SARS-CoV-2 IgG antibodies was found among PLHIV attending ART centre indicating an exposure to the virus among them.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
HIV Infections
/
COVID-19
Type of study:
Observational study
/
Prognostic study
/
Qualitative research
/
Randomized controlled trials
Limits:
Female
/
Humans
Country/Region as subject:
Asia
Language:
English
Journal:
J Int Assoc Provid AIDS Care
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS